Equity Details
Price & Market Data
Price: $4.40
Daily Change: -$0.10 / 2.27%
Daily Range: $4.20 - $4.62
Market Cap: $409,347,473
Daily Volume: 401,007
Performance Metrics
1 Week: 3.33%
1 Month: 5.08%
3 Months: 16.98%
6 Months: 16.98%
1 Year: 29.94%
YTD: 8.50%
About X4 Pharmaceuticals, Inc. (XFOR)
Explore comprehensive market data for X4 Pharmaceuticals, Inc. (XFOR). Currently priced at 4.40, observe its daily movement of -$0.10 / 2.27%. The total market value is 409,347,473. Review its performance across various timeframes, including the last week, month, and year, to understand its trajectory.
Company Details
Employees: 45
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
X4 Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system. It offers XOLREMDI, an orally small-molecule selective antagonist of chemokine receptor CXCR4, which is in phase 3 clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome. It has a license agreement with Abbisko Therapeutics Co Ltd. to manufacture and distribute XOLREMDI in mainland China, Taiwan, Hong Kong and Macau; Norgine to develop, manufacture, and commercialize mavorixafor in Europe, Australia, and New Zealand; and Genzyme Corporation for CXCR4 receptor to develop and commercialize products containing licensed compounds for all therapeutic, prophylactic and diagnostic uses. The company is headquartered in Boston, Massachusetts.